✦ LIBER ✦

Imaging Muscarinic Cholinergic Receptors in Human Brain In Vivo with SPECT, [123I]4-Iododexetimide, and [123I]4-lodolevetimide

✍ Scribed by Muller-Gartner, Hans W.; Wilson, Alan A.; Dannals, Robert F.; Wagner, Henry N.; Frost, J. James

Book ID: 109870564
Publisher: Nature Publishing Group
Year: 1992
Tongue: English
Weight: 780 KB
Volume: 12
Category: Article
ISSN: 0271-678X
DOI: 10.1038/jcbfm.1992.80

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of (R, R)123I-QNB, A spect ima

Synthesis of (R, R)123I-QNB, A spect imaging agent for cerebral muscarinic acetylcholine receptors in vivo

✍ J. Owens; T. Murray; J. McCulloch; D. Wyper 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 737 KB

## Abstract The high‐affinity muscarinic receptor antagonist (R,R) I‐QNB^(1)^ [(R)‐(‐)‐1‐Azabicyclo [2.2.2]oct‐3‐yl‐ (R) ‐ (+) ‐ α‐hydroxy‐α‐(4‐[^127^I]iodophenyl)‐α‐phenyl Acetate (6a)] has been labeled with iodine‐123 to give a suitable ligand for SPECT (Single photon emission computed tomography

4-123I - spiperone of high purity and hi

4-123I - spiperone of high purity and high specific activity. A suitable tracer for imaging dopamine receptor sites in baboon brains with spect

✍ J. Mertens; D. Terriere; A. Bossuyt; C. Bossuyt-Piron 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB

Recently there has been an increased urge towards y-labelled tracers for in vivo dopamine receptors studies in human brain with SPECT. As 99m Tc chelate compunds for that purpose remain wishfull thinking until now, only 123 I labelled molecules can actually fulfil the technical requirements of imagi

In vivo 123I IBZM SPECT imaging of stria

In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

✍ J. Tauscher; B. Küfferle; S. Asenbaum; P. Fischer; L. Pezawas; C. Barnas; S. Tau 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 105 KB

Synthesis, radiosynthesis and preliminar

Synthesis, radiosynthesis and preliminary in vivo evaluation of [123I]-(4-fluorophenyl) {1-[2-(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging

✍ P. Blanckaert; M. Vandecapelle; L. Staelens; I. Burvenich; R. A. Dierckx; G. Sle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 1 views

## Abstract Many people suffer from psychiatric illnesses like depression and anorexia. Relevant to these diseases is amongst others a malfunctioning of brain 5‐HT~2A~‐receptors. To allow __in vivo__ quantification of these receptors with Single Photon Emission Computerized Tomography (SPECT), a ra

[123I]Iodobenzamide binding to the rat d

[123I]Iodobenzamide binding to the rat dopamine D2receptor in competition with haloperidol and endogenous dopamine—an in vivo imaging study with a dedicated small animal SPECT

✍ Susanne Nikolaus; Rolf Larisch; Andreas Wirrwar; Marlyse Jamdjeu-Nouné; Christin 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 162 KB

6-[123I]Iodo-2-[[4-(2-methoxyphenyl) pip

6-[123I]Iodo-2-[[4-(2-methoxyphenyl) piperazin-1-yl]methyl]imidazo[1,2-a]pyridine as potential SPECT agent for imaging dopamine D4 receptor: synthesis and in vivo evaluation in a nonhuman primate

✍ David Alagille; Andrei O. Koren; Greg Kudej; Julie Staley; Kelly Cosgrove; John 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 1 views

## Abstract The dopamine D~4~ receptor subtype has drawn considerable attention due to its potential implication in schizophrenia and erectile dysfunction. 6‐[^123^I]Iodo‐2‐[[4‐(2‐methoxyphenyl)piperazin‐1‐yl]methyl]imidazo[1,2‐__a__]pyridine [^123^I]‐1, a potent and selective new dopamine D~4~ ago